Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Doximity is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-02Current report (material event)
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- ARS2026-07-15Annual report to holders
- DEFA14A2026-07-15DEFA14A
- DEF 14A2026-07-15Proxy statement
- S-82026-05-19Employee stock plan
- 10-K2026-05-19Annual report
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 8-K2026-05-13Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-17Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- UPLOAD2026-03-26UPLOAD
- CORRESP2026-03-23CORRESP
- UPLOAD2026-02-23UPLOAD
- 10-Q2026-02-05Quarterly report
- 8-K2026-02-05Current report (material event)
- SCHEDULE 13G/A2026-02-05SCHEDULE 13G/A
- 8-K2025-12-30Current report (material event)
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-06Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- 8-K2025-09-02Current report (material event)
- 8-K2025-08-15Current report (material event)
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-07Current report (material event)
- SCHEDULE 13G/A2025-08-06SCHEDULE 13G/A
- ARS2025-07-16Annual report to holders
- DEFA14A2025-07-16DEFA14A
- DEF 14A2025-07-16Proxy statement
- 8-K2025-06-13Current report (material event)
- S-82025-05-20Employee stock plan
- 10-K2025-05-20Annual report
- SCHEDULE 13G/A2025-05-15SCHEDULE 13G/A
- 8-K2025-05-15Current report (material event)
- SCHEDULE 13G/A2025-03-07SCHEDULE 13G/A
- SCHEDULE 13G/A2025-02-14SCHEDULE 13G/A
- SCHEDULE 13G/A2025-02-14SCHEDULE 13G/A
- SCHEDULE 13G/A2025-02-13SCHEDULE 13G/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.